Erratum: Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: Implications for clinical SPECT imaging of ischemic heart disease (European Journal of Nuclear Medicine and Molecular Imaging (2005) 32 (75-83) DOI: 10.1007/s00259-004-1622-x);Myocardial metabolism of 123I-BMIPP under low-dose dobutamine infusion: Implications for clinical SPECT imaging of ischemic heart disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 1, 2005, Pages 75-83

  Hosokawa, Ryohei ^a   Nohara, Ryuji ^b   Hirai, Taku ^d   Fujibayashi, Yasuhisa ^c   Fujita, Masatoshi ^a   Kambara, Naoshige ^a   Ohba, Muneo ^a   Tadamura, Eiji ^a   Kimura, Takeshi ^a   Kita, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

Author keywords

123I BMIPP; Dobutamine; Stunned myocardium

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DOBUTAMINE; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOPHARMACEUTICAL AGENT;

ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATION; REPERFUSION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; COMPARATIVE STUDY; DOG; DOSE RESPONSE; DRUG COMBINATION; DRUG INTERACTION; EVALUATION; HEART MUSCLE ISCHEMIA; IMAGE ENHANCEMENT; INTRAARTERIAL DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; STUNNED HEART MUSCLE;

ANIMALS; DOBUTAMINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; FATTY ACIDS; IMAGE ENHANCEMENT; INFUSIONS, INTRA-ARTERIAL; IODOBENZENES; MALE; METABOLIC CLEARANCE RATE; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 19944432801     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1782-3     Document Type: Erratum

References (22)

1. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial SPECT: current status and future perspectives. Eur J Nucl Med 1995;22:361-81.
2. Knapp FF Jr, Kropp J, Goodman MM, et al. The development of iodine-123-methyl-branched fatty acids and their applications in nuclear cardiology. Ann Nucl Med 1993;7:1-14.
3. Knapp FF Jr, Goodman MM, Ambrose KR, et al. The development of radioiodinated 3-methyl-branched fatty acids for evaluation of myocardial disease by single photon techniques. In: van der Wall EE, editor. Noninvasive imaging of cardiac metabolism. Dordrecht: Martius Nijhoff; 1987. p. 159-201.
4. Fujibayashi Y, Yonekura Y, Kawai K, et al. Basic studies on I-123-beta-methyl-R-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor. Jpn J Nucl Med 1988;25:1131-5.
5. 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease. J Nucl Med 1999;40:471-8.
6. Tamaki N, Kawamoto M, Yonekura Y et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using iodinated branched fatty acid analog. J Nucl Med 1992;33:659-67.
7. Franken PR, De Geeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-65.
8. Hanaoka S, Yamabe H, Abe H, et al. Improved uptake of fatty acid in metabolically stunned myocardium during dobutamine infusion after myocardial infarction. Circulation 1996;94:I-61.
9. Hosokawa R, Nohara R, Fujibayashi Y et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT. J Nucl Med 1997;38:1857-63.
10. Hosokawa R, Nohara R, Fujibayashi Y, et al. Metabolic fate of iodine-123 BMIPP in canine myocardium after administration of etomoxir. J Nucl Med 1996;37:1836-40.
11. Hale SL, Alker KJ, Kloner RA. Evaluation of non-radioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988;78:428-34.
12. Hartley CJ, Latson LA, Michael LH, et al. Doppler measurement of myocardial thickening with a single epicardial transducer. Am J Physiol 1983;245:H1066-72.
13. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996;37:757-61.
14. Folch J, Lees M. Proteolipides, a new type of tissue lipoproteins. J Biol Chem 1951;191:807-17.
15. Tateno M, Tamaki N, Kudoh T, et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996;37:1981-5.
16. Pierard LA, De Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.
17. La Canna G, Alfieri O, Giubbini R, et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
18. Fujiwara S, Takeishi Y, Atsumi H, et al. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997;38:175-80.
19. De Geeter F, Caveliers V, Pansar I, et al. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers. J Nucl Med 1998;39:1850-6.
20. Caveliers V, De Geeter F, Pansar I, et al. Effect of exercise induced hyperlactatemia on the biodistribution and metabolism of iodine-123-15-(p- iodophenyi)-3-R,S-methylpentadecanoic acid in normal volunteers. Eur J Nucl Med 2000;27:33-40.
21. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-85.
22. Takeda K, Saito K, Makino K, et al. Iodine-123-BMIPP myocardial washout and cardiac work during exercise in normal and ischemic hearts. J Nucl Med 1997;38:559-63.